Skip to content

Dr. Jorne Van Overloop

Active Private limited companyfounded 2017active for 9 yearsHondschotestraat 218, 8560 WevelgemKBO/BCE: BE 0670.539.323

Lifetime

9 annual accounts with figures on one time axis
peak of €297,901 in 2024
€276,344▼ 7.2%
lowest -€9,234 in 2018
€196,834▼ 8.0%
peak of €110,314 in 2022
€18,600unchanged
€192,979▼ 30.6%
Board1 name since 2017
1 director
Documentsfilings and deeds
05-06-202656 days before the deadline
2025micro format
Dividend €196,834Debts from €278,090 to €192,979Cash from €136,578 to €77,127

Key points

from the 2025 annual accounts

Equity

€18,600 from €110,314 in 2022

Equity fell by 83% in 3 years.

Turnover

≈ €420,000 estimated

The accounts state no turnover.

Debts

€192,979 91% of the balance sheet
Financial debts 13%Suppliers 3%Taxes and wages 15%Other 70%

Of this, €168,159 falls due within a year.

Filings

9 annual accounts 4 late
AprilJune31 JulyOctober20202025

The 2022 accounts came in latest, 31 days after the end of the period.

Position in the sector

8.8%

Lower solvency than 87% of companies in human health. The sector median is 63.0%, over 21,385 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,154 companies had the same profile as Dr. Jorne Van Overloop has now. Each dot stands for 6 companies, two years later.

96.0%
were still trading
2.3%
stopped another way
1.7%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,154 companies, not a prediction for Dr. Jorne Van Overloop. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 30-01-2017
  • 186 sharesdeed of 01-02-2017
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0670539323
Registered office moved from Kapelle-op-den-Bos to Gullegem The registered office moved from Oxdonkstraat 16, 1880 Kapelle-op-den-bos to Hondschotestraat 2018, 8560 Gullegem · Registered office in the articles: Oxdonkstraat 16, 1880 Kapelle-op-den-bos · Gazette deed
Registered office moved from Antwerp to Kapelle-op-den-Bos The registered office moved from Goedetijdstraat 65, 2660 Antwerpen to Oxdonkstraat 16, 1880 Kapelle-op-den-bos · changes role from manager to director · “De vennootschap heeft tot voorwerp het uitoefenen van de geneeskunde, met specialisatie anesthesie en…” (deed in Dutch) · General meeting of 14-06-2022 · Gazette deed
Incorporation Founding capital of €18,600, 186 shares, €12,400 paid up · Founded by · appointed as manager · published on 01-02-2017 · Gazette deed
All 20 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Jorne Van Overloop Wevelgem €211,579 €276,344 8.8% -
Dokter Casteleyn Ilse Torhout €217,865 €257,305 9.4% -
DR. O. MEEUS Duffel €218,327 €267,624 15.3% -
KINDERARZTPRAXIS DR. LATUS Raeren €228,285 €296,213 27.3% -
HENICOL Sint-Truiden €227,454 €291,543 94.6% -
DR. STEFAN CLOCKAERTS Rumst €189,073 €306,465 51.7% -
D. PEETERS PATHOLOGIE Lint €230,221 €273,999 8.1% -

These companies have the same main activity as Dr. Jorne Van Overloop: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €189,000 and €230,000, founded between 2017 and 2018.

Official details

Source: KBO
Status
Active since 30-01-2017Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.261.052.0838560 Wevelgem, since 30-01-2017
Financial year end
31 December
Peppol
Reachable since 12-08-2026
Company details

Annual accounts 2025

€211,579▼ 28.7%
Filing
Filed on 05-06-2026, 56 days before the end of the filing period
Financials

Insights on Dr. Jorne Van Overloop

Dr. Jorne Van Overloop files the micro format. That format states no turnover. The gross margin rose from €10,119 in 2017 to €276,344 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Jorne Van Overloop

What is the company number of Dr. Jorne Van Overloop?
The company number of Dr. Jorne Van Overloop is 0670.539.323. The VAT number is the same number with BE in front: BE 0670.539.323.
Where is Dr. Jorne Van Overloop based?
The registered office is at Hondschotestraat 218, 8560 Wevelgem.Company details
What does Dr. Jorne Van Overloop do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Jorne Van Overloop?
Dr. Jorne Van Overloop is a private limited company (BV).
When was Dr. Jorne Van Overloop founded?
Dr. Jorne Van Overloop was founded on 30-01-2017.
Is Dr. Jorne Van Overloop still active?
Yes, Dr. Jorne Van Overloop is an active enterprise in the KBO register.
What is the turnover of Dr. Jorne Van Overloop?
The turnover in financial year 2025 is about €420,000. This figure is estimated from the gross margin of €276,344 and 31 comparable companies (NACE 86220). It probably lies between €370,000 and €580,000.Financials
Is Dr. Jorne Van Overloop profitable?
In financial year 2025, Dr. Jorne Van Overloop made a profit of €196,834.
Where can I find the annual accounts of Dr. Jorne Van Overloop?
Dr. Jorne Van Overloop filed 9 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Jorne Van Overloop due?
Dr. Jorne Van Overloop must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.